XML 46 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Assumptions
The following weighted average assumptions were used to determine the fair value of the stock options granted on the original grant date for expense recognition purposes for options granted during the nine months ended September 30, 2018 and 2017 using a Black Scholes Model:
 
 
Nine months ended
 
September 30, 2018
 
September 30, 2017
Directors and Officers:
 
 
 
Expected dividend rate
$
0.26

 
$
0.26

Expected volatility
29.73
%
 
30.81
%
Risk-free interest rate
2.20
%
 
1.90
%
Expected life (in years)
5.0

 
5.0

 
 
 
 
Employees:
 

 
 

Expected dividend rate
$
0.26

 
$
0.26

Expected volatility
29.82
%
 
30.70
%
Risk-free interest rate
2.48
%
 
1.88
%
Expected life (in years)
5.0

 
5.0

Summary of Stock Options Outstanding
The following is a summary of stock options vested and exercisable as of September 30, 2018:
 
Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$5.67 - $32.80
 
362,715

 
5.54
 
$
18.14

 
$
7,132

$32.85 - $33.80
 
5,484

 
4.08
 
33.18

 
25

$34.00 - $40.60
 
81,417

 
5.87
 
34.32

 
283

Total
 
449,616

 
5.58
 
$
21.25

 
$
7,440

 
The following is a summary of stock options vested and exercisable as of September 30, 2017:

Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$4.54 - $22.76
 
374,792

 
4.61

 
$
10.96

 
$
4,209

$23.57 - $32.80
 
41,490

 
7.86

 
25.61

 
18

$32.85 - $37.30
 

 

 

 

Total
 
416,282

 
4.93

 
$
12.42

 
$
4,227

Summary of Stock Option Activity
A summary of option activity under the plans is as follows:

 
Shares
 
Weighted
Average
Exercise
Price
Outstanding at December 31, 2017
1,567,109

 
$
25.27

Granted
1,444,520

 
34.52

Exercised
(234,359
)
 
14.95

Forfeited or Expired
(229,244
)
 
32.84

Outstanding at September 30, 2018
2,548,026

 
$
30.80

Exercisable at September 30, 2018
449,616

 
$
21.25

Summary of Unvested Restricted Stock Awards
A summary of the unvested restricted stock awards is as follows:
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested at December 31, 2017
341,800

 
$
25.52

Granted
104,675

 
32.28

Vested
(102,333
)
 
24.68

Forfeited
(32,778
)
 
28.12

Unvested at September 30, 2018
311,364

 
$
27.80

Summary of Grant Date Fair Value of Awards During Period
A summary of share-based compensation is as follows:
 
 
Three months ended
 
Nine months ended
 
September 30,
2018
 
September 30,
2017
 
September 30,
2018
 
September 30,
2017
Grant date fair value of awards during the period:
(in thousands)
Options
$
53

 
$
121

 
$
12,633

 
$
3,628

Restricted stock
18

 

 
3,379

 
4,182

Total
$
71

 
$
121

 
$
16,012

 
$
7,810

Summary of Share-Based Compensation Expense
Share-based compensation expense:
 
 
 
 
 
 
 
Options
$
1,076

 
$
620

 
$
3,202

 
$
2,050

Restricted stock
839

 
811

 
2,412

 
2,910

Total
$
1,915

 
$
1,431

 
$
5,614

 
$
4,960

Summary of Income Tax Benefit Related to Share-Based Compensation
Income tax benefit/(deficiency) related to share-based compensation:
 
 
 
 
 
 
Options
$
379

 
$
126

 
$
980

 
$
1,411

Restricted stock
26

 
131

 
245

 
836

Total
$
405

 
$
257

 
$
1,225

 
$
2,247